AURIGENE ONCOLOGY LIMITED

The company is integrated drug discovery company focused on small molecule and peptide drug discovery and development from target identification and validation to pre-IND drug candidates in oncology and inflammation.

Aurigene Oncology Limited, is an unlisted public company incorporated on 10 August, 2001. It is classified as a public limited company and is located in , . It's authorized share capital is INR 240.00 cr and the total paid-up capital is INR 187.56 cr.

Aurigene Oncology Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2024. It's EBITDA has increased by 146.35% over the previous year. At the same time, it's book networth has increased by 22.78%.

The current status of Aurigene Oncology Limited is - Active.

The last reported AGM (Annual General Meeting) of Aurigene Oncology Limited, per our records, was held on 26 July, 2024.

The company has 7 directors - Venkateswara Prasad Gunupati, Satish Reddy Kallam, and others.

The Corporate Identification Number (CIN) of Aurigene Oncology Limited is U24239KA2001PLC029391. It's registered address is at 39/49(P)KIADB INDUSTRIAL AREA ELECTRONICS CITY PHASE II, BANGALORE, Karnataka, India, 560100, - 560100.